[go: up one dir, main page]

RU2018109121A3 - - Google Patents

Download PDF

Info

Publication number
RU2018109121A3
RU2018109121A3 RU2018109121A RU2018109121A RU2018109121A3 RU 2018109121 A3 RU2018109121 A3 RU 2018109121A3 RU 2018109121 A RU2018109121 A RU 2018109121A RU 2018109121 A RU2018109121 A RU 2018109121A RU 2018109121 A3 RU2018109121 A3 RU 2018109121A3
Authority
RU
Russia
Application number
RU2018109121A
Other versions
RU2018109121A (ru
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of RU2018109121A publication Critical patent/RU2018109121A/ru
Publication of RU2018109121A3 publication Critical patent/RU2018109121A3/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/86Oxygen and sulfur atoms, e.g. thiohydantoin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/41661,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
RU2018109121A 2015-09-10 2016-08-23 Кристаллическая форма ингибитора андрогеновых рецепторов и способ её получения RU2018109121A (ru)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
CN201510574141 2015-09-10
CN201510574141.9 2015-09-10
CN201610073458 2016-02-02
CN201610073458.9 2016-02-02
PCT/CN2016/096381 WO2017041622A1 (zh) 2015-09-10 2016-08-23 一种雄性激素受体抑制剂的结晶形式及其制备方法

Publications (2)

Publication Number Publication Date
RU2018109121A RU2018109121A (ru) 2019-10-10
RU2018109121A3 true RU2018109121A3 (ru) 2019-12-04

Family

ID=58240573

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2018109121A RU2018109121A (ru) 2015-09-10 2016-08-23 Кристаллическая форма ингибитора андрогеновых рецепторов и способ её получения

Country Status (23)

Country Link
US (1) US10150739B2 (ru)
EP (1) EP3348546B1 (ru)
JP (1) JP6843116B2 (ru)
KR (1) KR20180048939A (ru)
CN (1) CN107001284B (ru)
AU (1) AU2016318700B2 (ru)
BR (1) BR112018003258A2 (ru)
CA (1) CA2996674A1 (ru)
CY (1) CY1123027T1 (ru)
DK (1) DK3348546T3 (ru)
ES (1) ES2794568T3 (ru)
HR (1) HRP20200852T1 (ru)
HU (1) HUE050459T2 (ru)
LT (1) LT3348546T (ru)
MX (1) MX378282B (ru)
PL (1) PL3348546T3 (ru)
PT (1) PT3348546T (ru)
RS (1) RS60448B1 (ru)
RU (1) RU2018109121A (ru)
SI (1) SI3348546T1 (ru)
SM (1) SMT202000258T1 (ru)
TW (1) TWI708764B (ru)
WO (1) WO2017041622A1 (ru)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017041622A1 (zh) 2015-09-10 2017-03-16 江苏恒瑞医药股份有限公司 一种雄性激素受体抑制剂的结晶形式及其制备方法
CN112174895B (zh) * 2017-12-13 2022-06-21 江苏恒瑞医药股份有限公司 一种雄性激素受体抑制剂的晶型及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1790640A4 (en) * 2004-09-09 2009-07-29 Chugai Pharmaceutical Co Ltd NEW IMIDAZOLIDINE DERIVATIVE AND APPLICATION THEREOF
KR101579701B1 (ko) 2005-05-13 2015-12-22 더 리전트 오브 더 유니버시티 오브 캘리포니아 디아릴히단토인 화합물
WO2010118354A1 (en) * 2009-04-09 2010-10-14 Medivation Prostate Therapeutics, Inc. Substituted di-arylhydantoin and di-arylthiohydantoin compounds and methods for use thereof
RS61242B1 (sr) 2012-09-04 2021-01-29 Shanghai hengrui pharmaceutical co ltd Derivati imidazolina, postupci njihove pripreme i njihove primene u medicini
AU2013316754A1 (en) * 2012-09-11 2015-04-30 Dr. Reddy's Laboratories Limited Enzalutamide polymorphic forms and its preparation
CN104356068A (zh) * 2014-10-30 2015-02-18 杭州新博思生物医药有限公司 恩杂鲁胺新晶型及其制备方法
WO2017041622A1 (zh) 2015-09-10 2017-03-16 江苏恒瑞医药股份有限公司 一种雄性激素受体抑制剂的结晶形式及其制备方法

Also Published As

Publication number Publication date
LT3348546T (lt) 2020-07-27
JP2018526364A (ja) 2018-09-13
BR112018003258A2 (pt) 2018-09-25
CY1123027T1 (el) 2021-10-29
EP3348546A1 (en) 2018-07-18
US10150739B2 (en) 2018-12-11
KR20180048939A (ko) 2018-05-10
RS60448B1 (sr) 2020-07-31
MX378282B (es) 2025-03-10
JP6843116B2 (ja) 2021-03-17
PL3348546T3 (pl) 2020-09-21
AU2016318700B2 (en) 2020-05-07
MX2018002759A (es) 2018-08-01
SMT202000258T1 (it) 2020-07-08
TWI708764B (zh) 2020-11-01
HRP20200852T1 (hr) 2020-08-21
RU2018109121A (ru) 2019-10-10
TW201713628A (zh) 2017-04-16
CA2996674A1 (en) 2017-03-16
AU2016318700A1 (en) 2018-04-05
PT3348546T (pt) 2020-05-29
HUE050459T2 (hu) 2020-12-28
EP3348546B1 (en) 2020-04-29
DK3348546T3 (da) 2020-07-06
CN107001284A (zh) 2017-08-01
ES2794568T3 (es) 2020-11-18
SI3348546T1 (sl) 2020-09-30
EP3348546A4 (en) 2019-03-27
WO2017041622A1 (zh) 2017-03-16
CN107001284B (zh) 2019-11-22
US20180244628A1 (en) 2018-08-30

Similar Documents

Publication Publication Date Title
BR112018004949A2 (ru)
RU2018109121A3 (ru)
BR0003746B1 (ru)
BR0003751B1 (ru)
BR0009649B1 (ru)
BR0009373B1 (ru)
BR0009349B1 (ru)
BR0009182B1 (ru)
BR0008874B1 (ru)
BR0008789B1 (ru)
BR0008719B1 (ru)
BR0008604B1 (ru)
BR0008158B1 (ru)
BR0008132B1 (ru)
BR0007834B1 (ru)
BR0007747B1 (ru)
BR0007688B1 (ru)
BR0007672B1 (ru)
BR0007487B1 (ru)
BR0009942B1 (ru)
BR0006866B1 (ru)
BR0006854B1 (ru)
BR0006634B1 (ru)
BR0005085B1 (ru)
BR0005041B1 (ru)